Abstract
Helicobacter pylori associated duodenal ulcers occur in patches of gastric metaplasia. The pathogenesis of gastric metaplasia is unclear, but it has been produced in experimental animals by acute injury and has been shown to be present to a greater extent of H pylori positive subjects. This study aimed to discover if gastric metaplasia regressed with eradication of H pylori or healing of duodenal ulcers, or both. Thirty two duodenal ulcer patients with H pylori infection confirmed by biopsy urease test and by antral histological examination were studied. Patients were treated with triple therapy (deNol 240 mg twice daily, amoxycillin 500 mg three times daily, and metronidazole 400 mg three times daily) for two weeks after the first endoscopy and were subsequently re-endoscoped. Three duodenal bulb biopsy specimens were obtained per patient at each endoscopy. Biopsy sections were stained with haematoxylin and eosin to determine the severity of duodenitis, and with diastase periodic acid-Schiff/alcian blue to assess the extent of gastric metaplasia. Slides were assessed by two histopathologists unaware of treatment status. H pylori was eradicated in 63% of subjects and all ulcers were healed at follow up. The median extent of gastric metaplasia at the start of treatment and 6-18 months (median 10) after treatment was compared in the two groups. Gastric metaplasia declined in eradicators from 16% to 8% (p < 0.05) while in non-eradicators there was no significant change (25% initially and at follow up). A positive relation between extent of gastric metaplasia and duodenal inflammation score was present before treatment (r(s) = 0.74, p < 0.001) and was unchanged after treatment in the non-eradicator group (r(s) = 0.89, p < 0.001). In the eradicator group, however, the inflammation score had significantly declined (p < 0.02) and the close relation with gastric metaplasia was no longer present. These results suggest that H pylori itself is at least in part responsible for producing gastric metaplasia of the duodenum.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bayerdörffer E., Ottenjann R. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease. Scand J Gastroenterol Suppl. 1988;142:93–100. [PubMed] [Google Scholar]
- Blaser M. J. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis. 1990 Apr;161(4):626–633. doi: 10.1093/infdis/161.4.626. [DOI] [PubMed] [Google Scholar]
- Carrick J., Lee A., Hazell S., Ralston M., Daskalopoulos G. Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis. Gut. 1989 Jun;30(6):790–797. doi: 10.1136/gut.30.6.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caselli M., Trevisani L., Aleotti A., Bovolenta M. R., Stabellini G. Gastric metaplasia in duodenal bulb and Campylobacter-like organisms in development of duodenal ulcer. Dig Dis Sci. 1989 Sep;34(9):1374–1378. doi: 10.1007/BF01538072. [DOI] [PubMed] [Google Scholar]
- Fiocca R., Villani L., Turpini F., Turpini R., Solcia E. High incidence of Campylobacter-like organisms in endoscopic biopsies from patients with gastritis, with or without peptic ulcer. Digestion. 1987;38(4):234–244. doi: 10.1159/000199597. [DOI] [PubMed] [Google Scholar]
- Fitzgibbons P. L., Dooley C. P., Cohen H., Appleman M. D. Prevalence of gastric metaplasia, inflammation, and Campylobacter pylori in the duodenum of members of a normal population. Am J Clin Pathol. 1988 Dec;90(6):711–714. doi: 10.1093/ajcp/90.6.711. [DOI] [PubMed] [Google Scholar]
- Frierson H. F., Jr, Caldwell S. H., Marshall B. J. Duodenal bulb biopsy findings for patients with non-ulcer dyspepsia with or without Campylobacter pylori gastritis. Mod Pathol. 1990 May;3(3):271–276. [PubMed] [Google Scholar]
- Graham D. Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989 Feb;96(2 Pt 2 Suppl):615–625. doi: 10.1016/s0016-5085(89)80057-5. [DOI] [PubMed] [Google Scholar]
- Graham D. Y., Lew G. M., Klein P. D., Evans D. G., Evans D. J., Jr, Saeed Z. A., Malaty H. M. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992 May 1;116(9):705–708. doi: 10.7326/0003-4819-116-9-705. [DOI] [PubMed] [Google Scholar]
- Graham D. Y., Opekun A., Lew G. M., Evans D. J., Jr, Klein P. D., Evans D. G. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol. 1990 Apr;85(4):394–398. [PubMed] [Google Scholar]
- Johan G., Offerhaus A., Molyvas E. N., Hoedemaeker P. J. Helicobacter pylori infection of gastric mucin cell metaplasia: the duodenum revisited. J Pathol. 1990 Nov;162(3):239–243. doi: 10.1002/path.1711620310. [DOI] [PubMed] [Google Scholar]
- Jönsson K. A., Ström M., Bodemar G., Norrby K. Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease. Scand J Gastroenterol. 1988 May;23(4):433–441. doi: 10.3109/00365528809093891. [DOI] [PubMed] [Google Scholar]
- Kreuning J., vd Wal A. M., Kuiper G., Lindeman J. Chronic nonspecific duodenitis. A multiple biopsy study of the duodenal bulb in health and disease. Scand J Gastroenterol Suppl. 1989;167:16–20. doi: 10.3109/00365528909091303. [DOI] [PubMed] [Google Scholar]
- Marshall B. J., Barrett L. J., Prakash C., McCallum R. W., Guerrant R. L. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology. 1990 Sep;99(3):697–702. doi: 10.1016/0016-5085(90)90957-3. [DOI] [PubMed] [Google Scholar]
- Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
- Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Lancet. 1989 Jan 7;1(8628):1–6. [PubMed] [Google Scholar]
- Noach L. A., Rolf T. M., Bosma N. B., Schwartz M. P., Oosting J., Rauws E. A., Tytgat G. N. Gastric metaplasia and Helicobacter pylori infection. Gut. 1993 Nov;34(11):1510–1514. doi: 10.1136/gut.34.11.1510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rauws E. A., Tytgat G. N. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet. 1990 May 26;335(8700):1233–1235. doi: 10.1016/0140-6736(90)91301-p. [DOI] [PubMed] [Google Scholar]
- Tatsuta M., Iishi H., Yamamura H., Yamamoto R., Taniguchi H. Enhancement by tetragastrin of experimental induction of gastric epithelium in the duodenum. Gut. 1989 Mar;30(3):311–315. doi: 10.1136/gut.30.3.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tytgat G. N., Noach L., Rauws E. A. Helicobacter pylori. Scand J Gastroenterol Suppl. 1991;187:1–8. doi: 10.3109/00365529109098219. [DOI] [PubMed] [Google Scholar]
- Wright N. A., Pike C., Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 1990 Jan 4;343(6253):82–85. doi: 10.1038/343082a0. [DOI] [PubMed] [Google Scholar]
- Wyatt J. I., Rathbone B. J., Dixon M. F., Heatley R. V. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol. 1987 Aug;40(8):841–848. doi: 10.1136/jcp.40.8.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wyatt J. I., Rathbone B. J., Sobala G. M., Shallcross T., Heatley R. V., Axon A. T., Dixon M. F. Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol. 1990 Dec;43(12):981–986. doi: 10.1136/jcp.43.12.981. [DOI] [PMC free article] [PubMed] [Google Scholar]


